United States
— American news, politics, culture, and discussion“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote
A bill meant to show patients exactly where their generic drugs are made just lost its two toughest provisions before heading to a full Senate vote. Gone: a factory ID code tying labels to FDA inspection records, and a one-year deadline, now stretched to five.
— via ProPublica, Naisha Roy
Sort by Hot Top New Controversial
No comments yet
Be the first to share your thoughts.